Global Oncolytic Virus Drug Treatment Market Research Report 2024

Report ID: 1819178 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Clinical Stage
        1.2.1 Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Clinical Stage: 2017 VS 2021 VS 2028
        1.2.2 Phase 1
        1.2.3 Phase 2
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Oncolytic Virus Drug Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Melanoma
        1.3.3 Prostate Cancer
        1.3.4 Breast Cancer
        1.3.5 Ovarian Cancer
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Oncolytic Virus Drug Treatment Market Perspective (2017-2028)
    2.2 Oncolytic Virus Drug Treatment Growth Trends by Region
        2.2.1 Oncolytic Virus Drug Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Oncolytic Virus Drug Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Oncolytic Virus Drug Treatment Market Dynamics
        2.3.1 Oncolytic Virus Drug Treatment Industry Trends
        2.3.2 Oncolytic Virus Drug Treatment Market Drivers
        2.3.3 Oncolytic Virus Drug Treatment Market Challenges
        2.3.4 Oncolytic Virus Drug Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue
        3.1.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue (2017-2022)
        3.1.2 Global Oncolytic Virus Drug Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Oncolytic Virus Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Oncolytic Virus Drug Treatment Revenue
    3.4 Global Oncolytic Virus Drug Treatment Market Concentration Ratio
        3.4.1 Global Oncolytic Virus Drug Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Drug Treatment Revenue in 2021
    3.5 Oncolytic Virus Drug Treatment Key Players Head office and Area Served
    3.6 Key Players Oncolytic Virus Drug Treatment Product Solution and Service
    3.7 Date of Enter into Oncolytic Virus Drug Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Drug Treatment Breakdown Data by Clinical Stage
    4.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Clinical Stage (2017-2022)
    4.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Clinical Stage (2023-2028)
5 Oncolytic Virus Drug Treatment Breakdown Data by Application
    5.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Oncolytic Virus Drug Treatment Market Size (2017-2028)
    6.2 North America Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
    6.3 North America Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Oncolytic Virus Drug Treatment Market Size (2017-2028)
    7.2 Europe Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
    7.3 Europe Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Oncolytic Virus Drug Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Oncolytic Virus Drug Treatment Market Size (2017-2028)
    9.2 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
    9.3 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Oncolytic Virus Drug Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Detail
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Oncolytic Virus Drug Treatment Introduction
        11.1.4 Amgen Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.1.5 Amgen Recent Development
    11.2 Oncolytics Biotech
        11.2.1 Oncolytics Biotech Company Detail
        11.2.2 Oncolytics Biotech Business Overview
        11.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Introduction
        11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.2.5 Oncolytics Biotech Recent Development
    11.3 Viralytics
        11.3.1 Viralytics Company Detail
        11.3.2 Viralytics Business Overview
        11.3.3 Viralytics Oncolytic Virus Drug Treatment Introduction
        11.3.4 Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.3.5 Viralytics Recent Development
    11.4 Transgene SA
        11.4.1 Transgene SA Company Detail
        11.4.2 Transgene SA Business Overview
        11.4.3 Transgene SA Oncolytic Virus Drug Treatment Introduction
        11.4.4 Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.4.5 Transgene SA Recent Development
    11.5 Oncolys BioPharma
        11.5.1 Oncolys BioPharma Company Detail
        11.5.2 Oncolys BioPharma Business Overview
        11.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Introduction
        11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.5.5 Oncolys BioPharma Recent Development
    11.6 Targovax
        11.6.1 Targovax Company Detail
        11.6.2 Targovax Business Overview
        11.6.3 Targovax Oncolytic Virus Drug Treatment Introduction
        11.6.4 Targovax Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.6.5 Targovax Recent Development
    11.7 PsiOxus Therapeutics
        11.7.1 PsiOxus Therapeutics Company Detail
        11.7.2 PsiOxus Therapeutics Business Overview
        11.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Introduction
        11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.7.5 PsiOxus Therapeutics Recent Development
    11.8 SillaJen Biotherapeutics
        11.8.1 SillaJen Biotherapeutics Company Detail
        11.8.2 SillaJen Biotherapeutics Business Overview
        11.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Introduction
        11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.8.5 SillaJen Biotherapeutics Recent Development
    11.9 Sorrento Therapeutics
        11.9.1 Sorrento Therapeutics Company Detail
        11.9.2 Sorrento Therapeutics Business Overview
        11.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Introduction
        11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.9.5 Sorrento Therapeutics Recent Development
    11.10 Lokon Pharma
        11.10.1 Lokon Pharma Company Detail
        11.10.2 Lokon Pharma Business Overview
        11.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Introduction
        11.10.4 Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.10.5 Lokon Pharma Recent Development
    11.11 Genelux Corporation
        11.11.1 Genelux Corporation Company Detail
        11.11.2 Genelux Corporation Business Overview
        11.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Introduction
        11.11.4 Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.11.5 Genelux Corporation Recent Development
    11.12 Vyriad
        11.12.1 Vyriad Company Detail
        11.12.2 Vyriad Business Overview
        11.12.3 Vyriad Oncolytic Virus Drug Treatment Introduction
        11.12.4 Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.12.5 Vyriad Recent Development
    11.13 TILT Biotherapeutics
        11.13.1 TILT Biotherapeutics Company Detail
        11.13.2 TILT Biotherapeutics Business Overview
        11.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Introduction
        11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.13.5 TILT Biotherapeutics Recent Development
    11.14 Cold Genesys
        11.14.1 Cold Genesys Company Detail
        11.14.2 Cold Genesys Business Overview
        11.14.3 Cold Genesys Oncolytic Virus Drug Treatment Introduction
        11.14.4 Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2017-2022)
        11.14.5 Cold Genesys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Clinical Stage (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Phase 1
    Table 3. Key Players of Phase 2
    Table 4. Key Players of Others
    Table 5. Global Oncolytic Virus Drug Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Oncolytic Virus Drug Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Oncolytic Virus Drug Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Oncolytic Virus Drug Treatment Market Share by Region (2017-2022)
    Table 9. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Oncolytic Virus Drug Treatment Market Share by Region (2023-2028)
    Table 11. Oncolytic Virus Drug Treatment Market Trends
    Table 12. Oncolytic Virus Drug Treatment Market Drivers
    Table 13. Oncolytic Virus Drug Treatment Market Challenges
    Table 14. Oncolytic Virus Drug Treatment Market Restraints
    Table 15. Global Oncolytic Virus Drug Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Oncolytic Virus Drug Treatment Market Share by Players (2017-2022)
    Table 17. Global Top Oncolytic Virus Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Drug Treatment as of 2021)
    Table 18. Ranking of Global Top Oncolytic Virus Drug Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Oncolytic Virus Drug Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Oncolytic Virus Drug Treatment Product Solution and Service
    Table 22. Date of Enter into Oncolytic Virus Drug Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Oncolytic Virus Drug Treatment Market Size by Clinical Stage (2017-2022) & (US$ Million)
    Table 25. Global Oncolytic Virus Drug Treatment Revenue Market Share by Clinical Stage (2017-2022)
    Table 26. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Clinical Stage (2023-2028) & (US$ Million)
    Table 27. Global Oncolytic Virus Drug Treatment Revenue Market Share by Clinical Stage (2023-2028)
    Table 28. Global Oncolytic Virus Drug Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Oncolytic Virus Drug Treatment Revenue Market Share by Application (2017-2022)
    Table 30. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Oncolytic Virus Drug Treatment Revenue Market Share by Application (2023-2028)
    Table 32. North America Oncolytic Virus Drug Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Oncolytic Virus Drug Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Oncolytic Virus Drug Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Oncolytic Virus Drug Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Oncolytic Virus Drug Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Oncolytic Virus Drug Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Amgen Company Detail
    Table 43. Amgen Business Overview
    Table 44. Amgen Oncolytic Virus Drug Treatment Product
    Table 45. Amgen Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 46. Amgen Recent Development
    Table 47. Oncolytics Biotech Company Detail
    Table 48. Oncolytics Biotech Business Overview
    Table 49. Oncolytics Biotech Oncolytic Virus Drug Treatment Product
    Table 50. Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 51. Oncolytics Biotech Recent Development
    Table 52. Viralytics Company Detail
    Table 53. Viralytics Business Overview
    Table 54. Viralytics Oncolytic Virus Drug Treatment Product
    Table 55. Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 56. Viralytics Recent Development
    Table 57. Transgene SA Company Detail
    Table 58. Transgene SA Business Overview
    Table 59. Transgene SA Oncolytic Virus Drug Treatment Product
    Table 60. Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 61. Transgene SA Recent Development
    Table 62. Oncolys BioPharma Company Detail
    Table 63. Oncolys BioPharma Business Overview
    Table 64. Oncolys BioPharma Oncolytic Virus Drug Treatment Product
    Table 65. Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 66. Oncolys BioPharma Recent Development
    Table 67. Targovax Company Detail
    Table 68. Targovax Business Overview
    Table 69. Targovax Oncolytic Virus Drug Treatment Product
    Table 70. Targovax Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 71. Targovax Recent Development
    Table 72. PsiOxus Therapeutics Company Detail
    Table 73. PsiOxus Therapeutics Business Overview
    Table 74. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product
    Table 75. PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 76. PsiOxus Therapeutics Recent Development
    Table 77. SillaJen Biotherapeutics Company Detail
    Table 78. SillaJen Biotherapeutics Business Overview
    Table 79. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product
    Table 80. SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 81. SillaJen Biotherapeutics Recent Development
    Table 82. Sorrento Therapeutics Company Detail
    Table 83. Sorrento Therapeutics Business Overview
    Table 84. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product
    Table 85. Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 86. Sorrento Therapeutics Recent Development
    Table 87. Lokon Pharma Company Detail
    Table 88. Lokon Pharma Business Overview
    Table 89. Lokon Pharma Oncolytic Virus Drug Treatment Product
    Table 90. Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 91. Lokon Pharma Recent Development
    Table 92. Genelux Corporation Company Detail
    Table 93. Genelux Corporation Business Overview
    Table 94. Genelux Corporation Oncolytic Virus Drug TreatmentProduct
    Table 95. Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 96. Genelux Corporation Recent Development
    Table 97. Vyriad Company Detail
    Table 98. Vyriad Business Overview
    Table 99. Vyriad Oncolytic Virus Drug TreatmentProduct
    Table 100. Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 101. Vyriad Recent Development
    Table 102. TILT Biotherapeutics Company Detail
    Table 103. TILT Biotherapeutics Business Overview
    Table 104. TILT Biotherapeutics Oncolytic Virus Drug TreatmentProduct
    Table 105. TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 106. TILT Biotherapeutics Recent Development
    Table 107. Cold Genesys Company Detail
    Table 108. Cold Genesys Business Overview
    Table 109. Cold Genesys Oncolytic Virus Drug TreatmentProduct
    Table 110. Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2017-2022) & (US$ Million)
    Table 111. Cold Genesys Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncolytic Virus Drug Treatment Market Share by Clinical Stage: 2021 VS 2028
    Figure 2. Phase 1 Features
    Figure 3. Phase 2 Features
    Figure 4. Others Features
    Figure 5. Global Oncolytic Virus Drug Treatment Market Share by Application in 2021 & 2028
    Figure 6. Melanoma Case Studies
    Figure 7. Prostate Cancer Case Studies
    Figure 8. Breast Cancer Case Studies
    Figure 9. Ovarian Cancer Case Studies
    Figure 10. Others Case Studies
    Figure 11. Oncolytic Virus Drug Treatment Report Years Considered
    Figure 12. Global Oncolytic Virus Drug Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Oncolytic Virus Drug Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Oncolytic Virus Drug Treatment Market Share by Region: 2021 VS 2028
    Figure 15. Global Oncolytic Virus Drug Treatment Market Share by Players in 2021
    Figure 16. Global Top Oncolytic Virus Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Drug Treatment as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Oncolytic Virus Drug Treatment Revenue in 2021
    Figure 18. North America Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Oncolytic Virus Drug Treatment Market Share by Country (2017-2028)
    Figure 20. United States Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Oncolytic Virus Drug Treatment Market Share by Country (2017-2028)
    Figure 24. Germany Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Oncolytic Virus Drug Treatment Market Share by Region (2017-2028)
    Figure 32. China Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Oncolytic Virus Drug Treatment Market Share by Country (2017-2028)
    Figure 40. Mexico Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Oncolytic Virus Drug Treatment Market Share by Country (2017-2028)
    Figure 44. Turkey Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Oncolytic Virus Drug Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Amgen Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 47. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 48. Viralytics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 49. Transgene SA Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 50. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 51. Targovax Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 52. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 53. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 54. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 55. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 56. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 57. Vyriad Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 58. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 59. Cold Genesys Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Frequently Asked Questions
Oncolytic Virus Drug Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncolytic Virus Drug Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncolytic Virus Drug Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports